SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...
Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...
The treatment, which will be sold under the brand name Exdensur, is an “ultra-long-acting” version of a biologic treatment ...
Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...
Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...
An injected antibody reduced daily steroid pills in most people, and eliminated asthma attacks and the need for any pills at all in more than half of the people who received it The treatment, called ...
More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...
OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...
Fasenra is an injected medication that helps prevent severe asthma attacks (exacerbations) and may improve your breathing. Fasenra reduces blood eosinophils. About 50% of people with severe asthma ...
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback